Thymoorgan Gmbh Pharmazie
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Schiffgraben 23, Goslar OT Vienenburg, Lower Saxony 38690, Germany (DEU)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3002320821 · DUNS 319029989
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-04-25
- VAIDrug Quality Assurance2022-10-06
- VAIDrug Quality Assurance2019-06-20
- NAIDrug Quality Assurance2018-04-23
- NAIDrug Quality Assurance2016-12-16
- NAIDrug Quality Assurance2015-09-24
- VAIDrug Quality Assurance2014-05-22
- VAIDrug Quality Assurance2010-02-09
Drugs this plant is listed as making
4 distinct drugs across 7 products name this site in their FDA label.
- Azacitidinein shortageHikma Pharmaceuticals USA Inc.
- CisplatinHikma Pharmaceuticals USA Inc.
- FloxuridineJND Therapeutics, Inc.
- Irinotecan HydrochlorideHikma Pharmaceuticals USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.